---
created: '2026-02-09T05:54:33.116186Z'
description: Non-receptor tyrosine kinase that integrates signals from cell surface
  receptors to the cytoskeleton and nucleus.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/protein/src/
slug: src
tags:
- protein
- kinase
- oncogene
- cytoskeleton
- imported
- primekg
templateEngineOverride: njk
title: SRC
type: protein
updated: '2026-02-09T05:54:33.116186Z'
---

{% raw %}
<h1>SRC</h1>
<h2>Overview</h2>
<p><strong>Src (c-Src)</strong> is the prototype of the Src Family Kinases (SFKs). It is typically tethered to the inner face of the plasma membrane by myristoylation.</p>
<p>It is activated by receptor tyrosine kinases (like EGFR) and G-protein coupled receptors. Once activated, it phosphorylates focal adhesion kinase (FAK) and other substrates to promote:</p>
<ol>
<li><strong>Cell Migration</strong>: Remodeling the actin cytoskeleton.</li>
<li><strong>Cell Survival</strong>: Activating the PI3K-Akt pathway.</li>
<li><strong>Cell Proliferation</strong>: Activating the MAPK pathway.</li>
</ol>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>← [[STAT3]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:04.837263'
source: obsidian
</code></pre>
<ul>
<li>→ [[EGFR_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:04.662517'
source: obsidian
</code></pre>
<ul>
<li>→ [[Focal_Adhesion]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:04.662517'
source: obsidian
</code></pre>
<ul>
<li>→ [[Colorectal_Cancer]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:04.662517'
source: obsidian
</code></pre>
<ul>
<li>→ [[VEGF_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:04.662517'
source: obsidian
</code></pre>
<ul>
<li>← [[Melanoma]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:44.788008'
source: obsidian
</code></pre>
<ul>
<li>← [[Cancer]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:32.664708'
source: obsidian
</code></pre>
<ul>
<li>← [[EGFR]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:17.003644'
source: obsidian
</code></pre>
<ul>
<li>→ [[Bosutinib]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[Colorectal_Cancer]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[VEGF_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dasatinib]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[Focal_Adhesion]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[FAK]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[EGFR_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[STAT3]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[EGFR]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[Melanoma]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:33.887168'
source: obsidian
</code></pre>
<ul>
<li>→ [[SRC]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:46.919120'
source: obsidian
</code></pre>
<ul>
<li>→ [[Cancer]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:46.919120'
source: obsidian
</code></pre>
<ul>
<li>← [[UBC]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:34.416393'
source: obsidian
</code></pre>
<ul>
<li>→ [[UBC]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:04.662517'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Participates in Pathway</h3>
<ul>
<li>→ [[Focal Adhesion]] (pathway)</li>
<li>→ [[VEGF Signaling Pathway]] (pathway)</li>
<li>→ [[EGFR Signaling Pathway]] (pathway)</li>
</ul>
<h3>Interacts With</h3>
<ul>
<li>→ [[FAK]] (protein) - <em>Key substrate</em></li>
<li>→ [[EGFR]] (protein) - <em>Activator</em></li>
<li>→ [[STAT3]] (protein) - <em>Substrate</em></li>
</ul>
<h3>Targeted By</h3>
<ul>
<li>⊣ [[Dasatinib]] (drug) - <em>TKI (also targets BCR-ABL)</em></li>
<li>⊣ [[Bosutinib]] (drug) - <em>TKI</em></li>
</ul>
<h3>Related Conditions</h3>
<ul>
<li>→ [[Colorectal Cancer]] (condition) - <em>Frequently overactivated</em></li>
<li>→ [[Melanoma]] (condition)</li>
</ul>
<h2>References</h2>
<ol>
<li><strong>UniProt</strong>: P12931 (SRC_HUMAN)</li>
<li><strong>Review</strong>: Yeatman, T. J. (2004). &quot;A renaissance for SRC.&quot; <em>Nature Reviews Cancer</em>.</li>
</ol>

{% endraw %}